Appendix cancer other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
* Appendix cancer may also be diagnosed using [[scintigraphy]], [[Capsule endoscopy]], [[Enteroscopy]], [[Positron emission tomography]] (PET). Chromogranin A (CgA) and 5-HIAA (5-hydroxyindoleacetic acid) are among biochemical markers that might represent level of malignant cells activity in carcinoid syndrome. | |||
==Other Diagnostic Studies== | |||
* Appendix cancer may also be diagnosed using the following diagnostic studies: | * Appendix cancer may also be diagnosed using the following diagnostic studies: | ||
:* [[Somatostatin]] [[scintigraphy]] with 111-indium-octreotide | :* [[Somatostatin]] [[scintigraphy]] with 111-indium-octreotide | ||
Line 10: | Line 12: | ||
:* [[Enteroscopy]] | :* [[Enteroscopy]] | ||
:* [[Positron emission tomography]] (PET) | :* [[Positron emission tomography]] (PET) | ||
* The following are among biochemocal markers that might represent level of malignant cells activity in carcinoid syndrome. | |||
:* Chromogranin A (CgA) | :* Chromogranin A (CgA) | ||
:* 5-HIAA (5-hydroxyindoleacetic acid) | :* 5-HIAA (5-hydroxyindoleacetic acid) | ||
==References== | ==References== |
Revision as of 20:16, 24 January 2019
Appendix cancer Microchapters |
Diagnosis |
---|
Treatment |
Appendix cancer other diagnostic studies On the Web |
American Roentgen Ray Society Images of Appendix cancer other diagnostic studies |
Risk calculators and risk factors for Appendix cancer other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
- Appendix cancer may also be diagnosed using scintigraphy, Capsule endoscopy, Enteroscopy, Positron emission tomography (PET). Chromogranin A (CgA) and 5-HIAA (5-hydroxyindoleacetic acid) are among biochemical markers that might represent level of malignant cells activity in carcinoid syndrome.
Other Diagnostic Studies
- Appendix cancer may also be diagnosed using the following diagnostic studies:
- Somatostatin scintigraphy with 111-indium-octreotide
- Bone scintigraphy with 99mTc-methylene diphosphonate (99mTcMDP)
- Capsule endoscopy
- Enteroscopy
- Positron emission tomography (PET)
- The following are among biochemocal markers that might represent level of malignant cells activity in carcinoid syndrome.
- Chromogranin A (CgA)
- 5-HIAA (5-hydroxyindoleacetic acid)